Synthesis and activity of novel indirubin derivatives

Chem Biol Drug Des. 2021 Mar;97(3):565-571. doi: 10.1111/cbdd.13792. Epub 2020 Sep 21.

Abstract

A series of indirubin derivatives hydrochloride were obtained using a convenient and mild method from indirubin. The newly synthesized compounds and their derivatives were characterized by 1 H NMR, 13 C NMR, and MS. Furthermore, we tested their IDO1 enzyme inhibitory activity and anti-proliferative activities in K562 tumor cells. The experimental results revealed that some of the compounds showed potential anti-enzyme and anti-tumor activity. Among of them, compound 4b exhibited certain inhibitory activity on IDO1 (IC50 : 29.52 μmol/L), and compound 4a displayed activity similar to indirubin in K562 tumor cells (IC50 : 24.96 μmol/L). This type of indirubin derivative is expected to have the potential to act as an immunologically active anti-tumor drug, indicating that further research will be worthwhile.

Keywords: IDO1 enzyme inhibitory activity; anti-proliferative activities; indirubin derivatives; synthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / chemical synthesis*
  • Antineoplastic Agents / metabolism
  • Antineoplastic Agents / pharmacology
  • Binding Sites
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / antagonists & inhibitors
  • Indoleamine-Pyrrole 2,3,-Dioxygenase / metabolism
  • Indoles / chemistry
  • Indoles / metabolism
  • Indoles / pharmacology
  • Molecular Docking Simulation
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Enzyme Inhibitors
  • IDO1 protein, human
  • Indoleamine-Pyrrole 2,3,-Dioxygenase
  • Indoles
  • indirubin